Prime Medicine Statistics
NASDAQ: PRMEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.55-0.29 (-7.55%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Prime Medicine by the numbers
Prime Medicine has a market capitalization of $791.6 million based on 222.99M shares outstanding. With trailing EPS of $-0.97, Prime Medicine is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.0% below its 50-day average and 1.2% above its 200-day average.
Average daily trading volume is 4.64M shares, or about $16.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PRME valuation vs. peer median
| Metric | PRME | Peer median | Difference |
|---|---|---|---|
| Market cap | $791.62M | $759.09M | +4% |
| Avg. volume | 4.64M | 842.23K | +451% |
Peer median across 8 companies: MGTX, BBTX, ODTX, GLUE, AURA, IMTX, SLDB, ATTO.
Valuation
- Market cap
- $791.62M
- Price / sales (latest FY)
- 170.90
- EPS (TTM)
- $-0.97
- Shares outstanding
- 222.99M
Price and trading
- Previous close
- 3.84
- Open
- 3.70
- Day range
- 3.49 – 3.93
- 52-week range
- 2.67 – 5.91
- 52-week change
- -2.20%
- Beta
- —
- Volume
- 6.13M
- Average volume
- 4.64M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 791.62M
- Forward Pe
- -4.30
- Eps
- -0.97
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.91
- Week52 Low
- 2.67
- Avg Volume
- 4.64M
- Shares Outstanding
- 222.99M
- Ma50
- 3.74
- Ma200
- 3.51
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -39.93%
- Pct From52w Low
- 32.96%